Will India have Rs 80,000 crore for Covid-19 vaccine, asks Serum’s Poonawalla

The Serum Institute is at present conducting phase-III human trials for the corona vaccine developed by Oxford University-AstraZeneca called Covishield.

from The Financial Express https://ift.tt/341UDr9
https://ift.tt/eA8V8J FE Bureau